切换至 "中华医学电子期刊资源库"

中华介入放射学电子杂志 ›› 2017, Vol. 05 ›› Issue (02) : 79 -82. doi: 10.3877/cma.j.issn.2095-5782.2017.02.005

所属专题: 文献

血管介入

C臂锥体束CT技术在前列腺动脉栓塞术中的应用价值
王福安1, 黄文诺1, 吕朋华1, 孙陵1, 王书祥1, 徐川1, 李贵玲2,()   
  1. 1. 225001 江苏省苏北人民医院介入放射科
    2. 225001 江苏省苏北人民医院医学检验科
  • 收稿日期:2017-02-26 出版日期:2017-05-01
  • 通信作者: 李贵玲

A preliminary study on application value of Cone Beam CT in prostate arterial embolization

Fuan Wang1, Wennuo Huang1, Penghua Lyu1, Ling Sun1, Shuxiang Wang1, Chuan Xu1, Guiling Li2,()   

  1. 1. Department of Interventional Radiology, Subei People's Hospital of Jiangsu Province, Yangzhou 225001, China
    2. Department of Clinical Laboratory Medicine, Subei People's Hospital of Jiangsu Province, Yangzhou 225001, China
  • Received:2017-02-26 Published:2017-05-01
  • Corresponding author: Guiling Li
  • About author:
    Corresponding author: Li Guiling, Email:
引用本文:

王福安, 黄文诺, 吕朋华, 孙陵, 王书祥, 徐川, 李贵玲. C臂锥体束CT技术在前列腺动脉栓塞术中的应用价值[J/OL]. 中华介入放射学电子杂志, 2017, 05(02): 79-82.

Fuan Wang, Wennuo Huang, Penghua Lyu, Ling Sun, Shuxiang Wang, Chuan Xu, Guiling Li. A preliminary study on application value of Cone Beam CT in prostate arterial embolization[J/OL]. Chinese Journal of Interventional Radiology(Electronic Edition), 2017, 05(02): 79-82.

目的:

初步评价C臂锥体束CT(Cone Beam CT,CBCT)技术在前列腺动脉栓塞术(PAE)治疗前列腺增生中的临床应用价值。

方法:

回顾性分析2015年6月—2016年12月在我院进行前列腺动脉栓塞治疗的12例前列腺增生患者的临床资料,所有患者在进行前列腺动脉插管造影时均进行CBCT检查,以明确前列腺动脉的正确插管位置,预防非靶器官的误栓。经CBCT证实后,在透视下用100~300 μm直径的聚乙烯醇(PVA)颗粒栓塞前列腺动脉,术后观察患者血尿症状、排尿困难的改善情况及是否出现并发症。

结果:

所有患者在DSA下超选择插管后均行CBCT检查并证实为前列腺动脉再行栓塞治疗。10例(83.3%)患者完成双侧前列腺动脉栓塞,2例(16.7%)患者因血管扭曲插管困难行单侧前列腺动脉栓塞。8例患者术后1~2周内成功拔除尿管,在1个月随访时排尿保持通畅,有效率67.7%(8/12)。3例合并血尿症状的患者术后出血即停止,1个月随访未出现血尿症状,止血有效率100%。所有患者均未出现因膀胱、直肠、阴茎等邻近器官供血动脉栓塞导致的缺血坏死等严重并发症。

结论:

CBCT在动脉栓塞治疗前列腺增生疾病中有着重要作用,是保证前列腺动脉充分栓塞和避免误栓的重要影像学监测手段。

Objective:

To evaluate the clinical value of Cone Beam CT(CBCT) technology in prostatic artery embolization (PAE) in treating prostatic hyperplasia.

Methods:

A retrospective analysis of clinical data of 12 patients with benign prostate hyperplasia who received PAE in our department during June 2015 to December 2016 was performed. Polyvinyl alcohol (PVA) particles were used as embolization agent intraoperatively. CBCT was running during the PAE procedure to ensure a clear prostate gland artery intubation, preventing non-target organs embolization by mistake. Confirmed by CBCT, 100 μm to 300 μm diameter of PVA particles were injected into the prostate gland artery. The postoperative follow-up was made to observe these patients status with hematuria and any complications caused by embolization.

Results:

All of the patients were performed CBCT examination under DSA. 10 patients (83.3%) received bilateral prostatic artery embolism while the other 2 (16.7%) patients received unilateral prostatic artery embolism due to curved artery. All patients received embolization with CBCT imaging confirmation. 8 patients’ urine tubes were removed successfully 1~2 weeks after the procedure, and these patients kept urine unobstructed without hematuria in the follow-up a month later, with efficiency being 67.7% (8/12) . Among the 3 patients with hematuria symptoms, the blood did not appear in the urine during the follow-up, thus, the hemostatic effectiveness was 100%. No serious complications of ischemic necrosis in adjacent organs such as the bladder, rectum, and penis were observed.

Conclusion:

CBCT plays an important role in guiding PAE in precision and avoiding the postoperative complications.

图1 典型病例(82岁老年男性,巨大前列腺增生伴排尿困难及血尿症状)行前列腺动脉栓塞术
1
Zhang G, Wang M, Duan F, et al. Radiological findings of prostatic arterial anatomy for prostatic arterial embolization: preliminary study in 55 chinese patients with benign prostatic hyperplasia[J]. PLoS One, 2015, 10(7):e0132678. doi: 10.1371/journal.pone.0132678.
2
Wang MQ, Guo LP, Zhang GD, et al. Prostatic arterial embolization for the treatment of lower urinary tract symptoms due to large (>80 mL) benign prostatic hyperplasia: results of midterm follow-up from Chinese population[J]. BMC Urol, 2015, 15:33. doi: 10.1186/s12894-015-0026-5.
3
张国栋,段峰,袁凯, 等. 前列腺动脉栓塞术治疗良性前列腺增生症的前景与挑战[J]. 介入放射学杂志, 2014, 23(8):735-738. doi: 10.3969/j.issn.1008-794X.2014.08.021.
4
Bagla S, Rholl KS, Sterling KM, et al. Utility of cone-beam CT imaging in prostatic artery embolization[J]. J Vasc Interv Radiol, 2013, 24(11):1603-1607. doi: 10.1016/j.jvir.2013.06.024.
5
McWilliams JP, Kuo MD, Rose SC, et al. Society of Interventional Radiology position statement: prostate artery embolization for treatment of benign disease of the prostate[J]. J Vasc Interv Radiol, 2014, 25(9):1349-1351. doi: 10.1016/j.jvir.2014.05.005.
6
Gao YA, Huang Y, Zhang R, et al. Benign prostatic hyperplasia: prostatic arterial embolization versus transurethral resection of the prostate--a prospective, randomized, and controlled clinical trial[J]. Radiology, 2014, 270(3):920-928. doi: 10.1148/radiol.13122803.
7
Martins Pisco J. Prostatic arterial embolization[J]. Tech Vasc Interv Radiol, 2012, 15(4):255. doi: 10.1053/j.tvir.2012.09.001.
8
Fernandes L, Rio Tinto H, Pereira J, et al. Prostatic arterial embolization: post-procedural follow-up[J]. Tech Vasc Interv Radiol, 2012, 15(4):294-299. doi: 10.1053/j.tvir.2012.09.008.
9
Pisco JM, Pinheiro LC, Bilhim T, et al. Prostatic arterial embolization to treat benign prostatic hyperplasia[J]. J Vasc Interv Radiol, 2011, 22(1):11-19; quiz 20. doi: 10.1016/j.jvir.2010.09.030.
10
Sun F, Sánchez FM, Crisóstomo V, et al. Benign prostatic hyperplasia: transcatheter arterial embolization as potential treatment--preliminary study in pigs[J]. Radiology, 2008, 246(3):783-789. doi: 10.1148/radiol.2463070647.
11
徐慧琴,薛杨央,赵学峰,等. 18F-FDG PET-CT诊断前列腺癌复发与转移的价值[J]. 国际放射医学核医学杂志 2011,35(2):81-84.doi:10.3760/cma.j.issn.1673-4114.2011.02.004.
12
Bagla S, Sterling KM. Pitfalls of cone beam computed tomography in prostate artery embolization[J]. Cardiovasc Intervent Radiol, 2014, 37(6):1430-1435. doi: 10.1007/s00270-014-0982-2.
[1] 李国煜, 丛赟, 祖丽胡马尔·麦麦提艾力, 何铁英. 急性胰腺炎并发门静脉系统血栓形成的危险因素及预测模型构建[J/OL]. 中华普通外科学文献(电子版), 2024, 18(04): 266-270.
[2] 常小伟, 蔡瑜, 赵志勇, 张伟. 高强度聚焦超声消融术联合肝动脉化疗栓塞术治疗原发性肝细胞癌的效果及安全性分析[J/OL]. 中华普外科手术学杂志(电子版), 2025, 19(01): 56-59.
[3] 李想, 郭征, 田洪哲, 李杜, 熊梦瑶, 潘铁军. 1 470 nm半导体激光减容性切除治疗高危前列腺增生的临床研究[J/OL]. 中华腔镜泌尿外科杂志(电子版), 2024, 18(05): 448-452.
[4] 程志刚, 魏辉, 李一波, 韩健, 钟永豪, 王铭, 张文辉, 周传东. 经尿道前列腺剜除术中保留前列腺分叶沟间组织对术后顺行射精功能的保护[J/OL]. 中华腔镜泌尿外科杂志(电子版), 2024, 18(05): 453-458.
[5] 莫林键, 杨舒博, 农卫赟, 程继文. 人工智能虚拟数字医师在钬激光前列腺剜除日间手术患教管理中的应用[J/OL]. 中华腔镜泌尿外科杂志(电子版), 2024, 18(04): 318-322.
[6] 麦子结, 曾学晴, 张乾升, 刘永达. 输尿管软镜术后严重出血治疗的初步探索[J/OL]. 中华腔镜泌尿外科杂志(电子版), 2024, 18(04): 366-371.
[7] 张春玉, 陈海云, 肖忠萍, 罗琴, 潘运昌. 血清NT-proBNP 预测肺栓塞心脏功能障碍的临床分析[J/OL]. 中华肺部疾病杂志(电子版), 2024, 17(05): 805-808.
[8] 公宇, 廖媛, 尚梅. 肝细胞癌TACE术后复发影响因素及预测模型建立[J/OL]. 中华肝脏外科手术学电子杂志, 2024, 13(06): 818-824.
[9] 李一帆, 朱帝文, 任伟新, 鲍应军, 顾俊鹏, 张海潇, 曹耿飞, 阿斯哈尔·哈斯木, 纪卫政. 血GP73水平在原发性肝癌TACE疗效评价中的作用[J/OL]. 中华肝脏外科手术学电子杂志, 2024, 13(06): 825-830.
[10] 刘华亭, 张媛, 张登文, 王杰, 袁阳. 介入栓塞联合手术切除治疗头皮动静脉畸形的疗效观察[J/OL]. 中华神经创伤外科电子杂志, 2024, 10(05): 273-278.
[11] 蔡晓雯, 李慧景, 丘婕, 杨翼帆, 吴素贤, 林玉彤, 何秋娜. 肝癌患者肝动脉化疗栓塞术后疼痛风险预测模型的构建及验证[J/OL]. 中华临床医师杂志(电子版), 2024, 18(08): 722-728.
[12] 于洁, 金小红, 顾艳楣, 王慧, 葛杨杨, 李燕. 癌症相关静脉血栓栓塞症患者疾病体验与需求的质性研究[J/OL]. 中华临床医师杂志(电子版), 2024, 18(08): 739-744.
[13] 崔伟, 邓屹, 叶苏意, 李静, 陈晓明, 张靖, 许荣德. 载药微球支气管动脉化疗栓塞术治疗罕见非小细胞肺癌的临床疗效和安全性分析[J/OL]. 中华介入放射学电子杂志, 2024, 12(04): 303-310.
[14] 崔伟, 叶苏意, 邓屹, 陈晓明, 张靖, 李静, 许荣德. 载药微球支气管动脉化疗栓塞术治疗难治性非小细胞肺癌的临床疗效及安全性[J/OL]. 中华介入放射学电子杂志, 2024, 12(04): 311-316.
[15] 王卫明, 张艺菲, 陈炜, 秦浩, 杨宇光, 王俊, 王琴, 夏莹, 施博文, 董宇超, 白冲, 黄海东. 左主支气管动脉肺静脉瘘致气道狭窄及反复咯血一例[J/OL]. 中华介入放射学电子杂志, 2024, 12(04): 323-326.
阅读次数
全文


摘要


AI


AI小编
你好!我是《中华医学电子期刊资源库》AI小编,有什么可以帮您的吗?